MedTrace Logo

Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation

NCT00529594 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2007-09-14

No results posted yet for this study

Summary

The study wants to show if the medication etoricoxib 120 mg have reduces the patients pain during the laser photocoagulation, for diabetic retinopathy.

Conditions

  • Proliferative Diabetic Retinopathy

Interventions

DRUG

placebo (Control Group)

Both medication have been given to the patients in both groups 1 hour prior the laser photocoagulation

DRUG

Etoricoxib (Treatment Group)

Both medication have been given to the patients in both groups 1 hour prior the laser photocoagulation

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Vinicius P Nascimento, MD · Clinica Oftalmologica do Hospital das Clinicas da Universidade de São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Completion
2006-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00529594 on ClinicalTrials.gov